934841-17-5

934841-17-5 structure
934841-17-5 structure

Name tert-butyl (3S,5S)-2-oxo-5-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate
Synonyms (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester
(3S,5S)-3-(1-Methylethyl)-2-oxo-5-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]-1-pyrrolidinecarboxylic acid tert-butyl ester
(3S,5S)-tert-Butyl 3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-2-oxopyrrolidine-1-carboxylate
Molecular Formula C19H31NO5
Molecular Weight 353.45300
Exact Mass 353.22000
PSA 72.91000
LogP 3.32020

~%

934841-17-5 structure

934841-17-5

Literature: NOVARTIS AG; NOVARTIS PHARMA GmbH Patent: WO2007/45420 A2, 2007 ; Location in patent: Page/Page column 63-64 ;

~%

934841-17-5 structure

934841-17-5

Literature: NOVARTIS AG Patent: WO2008/119804 A1, 2008 ; Location in patent: Page/Page column 61-62 ; WO 2008/119804 A1
Precursor  2

DownStream  1